Evolution of the Virbac Board of Directors

On September 17, Eline Madelpuech was appointed non-voting board member to the Virbac Board of Directors, while Olivier Charmeil, who already serves as an independent director, joins its Audit Committee.

Holding a master's degree in medicine from the University of Liège (specializing in general medicine), an MBA from INSEAD, and being the granddaughter of the Group's founder, Eline Madelpuech brings to the board her medical expertise as well as her strategy and business development experience acquired within a human healthcare laboratory. As a non-voting board member, she attends meetings in an advisory capacity. Her diverse background in healthcare and strategic development will enhance the board's forward-looking discussions.

Furthermore, Olivier Charmeil, who is already an independent director and member of the Appointments and Compensation Committee, joins Virbac's Audit Committee-currently composed of Philippe Capron (Chairman), Pierre Madelpuech, and Cyrille Petit-thereby helping to ensure the committee's strict independence over time.

The Audit Committee, which supports the work of the Board of Directors, is responsible for ensuring the quality and reliability of the Group's financial, accounting, and sustainability information. It also monitors the effectiveness of internal control systems, risk management, and compliance programs. This evolution reflects Virbac's ongoing commitment to aligning its governance with the highest standards and supporting its sustainable growth.